Yüklüyor......
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
Gene therapy products for the treatment of genetic diseases are currently in clinical trials, and one of these, an adeno-associated viral (AAV) product, has recently been licensed. AAV vectors have achieved positive results in a number of clinical and preclinical settings, including hematologic diso...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Hematology
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3701904/ https://ncbi.nlm.nih.gov/pubmed/23596044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-01-306647 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|